← Leaderboards
Jae-Wook Jeong
University Of Missouri-Columbia
$12,793,611
Attributed
$14,983,137
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,983,137 · 8
By mechanism
R01$13,118,787 · 6
P01$1,864,350 · 2
Top collaborators
- Taeho Kim4 shared
- Bruce A. Lessey4 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Steven L Young$7,085,914
- Martin M Matzuk$44,230,622
- Bruce A. Lessey$2,222,327
- Matthew C Lucy$1,590,694
- Ov D Slayden$15,947,398
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMouse ModelWomanUterusGenesInfertilityMolecularEndometrialEstrogensReproductiveEndometriumPregnancyImplantationAnimal ModelMediatingTissuesInnovationEndometriosisEndometriosis-Related InfertilityProgesteroneFunctional DisorderResistanceResponseExperimental Study
Grant awards (38)
Development of anti-inflammatory nanodrug for endometriosis treatment$628,601
R01 · FY2025 · HD
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer$549,366
R01 · FY2025 · CA · contact PI
Epigenetic regulation of receptive endometrium$548,735
R01 · FY2025 · HD · contact PI
SIRT1 as a Therapeutic Target in Endometriosis$349,465
P01 · FY2025 · HD · contact PI
Development of anti-inflammatory nanodrug for endometriosis treatment$622,314
R01 · FY2024 · HD
Epigenetic regulation of receptive endometrium$569,935
R01 · FY2024 · HD · contact PI
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer$521,456
R01 · FY2024 · CA · contact PI
Molecular mechanisms of endometrial progesterone resistance$509,548
R01 · FY2024 · HD · contact PI
SIRT1 as a Therapeutic Target in Endometriosis$346,138
P01 · FY2024 · HD · contact PI
Development of anti-inflammatory nanodrug for endometriosis treatment$628,601
R01 · FY2023 · HD
Epigenetic regulation of receptive endometrium$587,153
R01 · FY2023 · HD · contact PI
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer$540,852
R01 · FY2023 · CA · contact PI
Molecular mechanisms of endometrial progesterone resistance$514,696
R01 · FY2023 · HD · contact PI
SIRT1 as a Therapeutic Target in Endometriosis$424,678
P01 · FY2023 · HD · contact PI
Development of anti-inflammatory nanodrug for endometriosis treatment$612,857
R01 · FY2022 · HD
Molecular mechanisms of endometrial progesterone resistance$469,500
R01 · FY2022 · HD · contact PI
Epigenetic regulation of receptive endometrium$430,000
R01 · FY2022 · HD · contact PI
SIRT1 as a Therapeutic Target in Endometriosis$358,267
P01 · FY2022 · HD · contact PI
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer$329,196
R01 · FY2022 · CA · contact PI
The role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer$254,927
R01 · FY2022 · CA · contact PI
Epigenetic regulation of receptive endometrium$161,191
R01 · FY2022 · HD · contact PI
Molecular mechanisms of endometrial progesterone resistance$45,196
R01 · FY2022 · HD · contact PI
Epigenetic regulation of receptive endometrium$606,819
R01 · FY2021 · HD · contact PI
Molecular mechanisms of endometrial progesterone resistance$514,696
R01 · FY2021 · HD · contact PI
SIRT1 as a Therapeutic Target in Endometriosis$385,802
P01 · FY2021 · HD · contact PI
Molecular mechanisms of endometrial progesterone resistance$557,047
R01 · FY2020 · HD · contact PI
Risk factors for early pregnancy loss$321,625
R01 · FY2020 · HD · contact PI
Risk factors for early pregnancy loss$321,625
R01 · FY2019 · HD · contact PI
Risk factors for early pregnancy loss$321,625
R01 · FY2018 · HD · contact PI
Risk factors for early pregnancy loss$321,625
R01 · FY2017 · HD · contact PI
Risk factors for early pregnancy loss$320,847
R01 · FY2016 · HD · contact PI
Steroid Hormone Regulation of Uterine Function and Dysfunction$248,007
R01 · FY2012 · HD · contact PI
Steroid Hormone Regulation of Uterine Function and Dysfunction$248,007
R01 · FY2011 · HD · contact PI
Steroid Hormone Regulation of Uterine Function and Dysfunction$228,304
R01 · FY2010 · HD · contact PI
Steroid Hormone Regulation of Uterine Function and Dysfunction$32,793
R01 · FY2010 · HD · contact PI
Steroid Hormone Regulation of Uterine Function and Dysfunction$29,743
R01 · FY2010 · HD · contact PI
Steroid Hormone Regulation of Uterine Function and Dysfunction$260,950
R01 · FY2009 · HD · contact PI
Steroid Hormone Regulation of Uterine Function and Dysfunction$260,950
R01 · FY2008 · HD · contact PI